Financings
Xigem Technologies Announces Closing of Shares for Debt Transactions
Debt Settlement Confirms Liquidity Strain Amidst Customer Default

Executive Summary
- Xigem Technologies closed a transaction on May 19, 2026, to settle $523,230 in outstanding accounts payable by issuing 10,464,595 common shares at $0.05 per share.
- The transaction involves related party participants: CEO Brian Kalish and a company related to CFO Igor Kostioutchenko received the majority of settlement shares (7,752,595).
- All issued shares are subject to a four-month and one-day hold period.
- This follows an announcement on May 11, 2026, regarding the intention to issue shares for debt settlement.
- Prior to this, on April 27, 2026, the company reported that Carnance Inc., its sole customer for the EchoDigital business unit, defaulted on a $500,000 tripartite loan agreement.
Material Impact
- The debt settlement confirms dilution of approximately 10.4 million shares, which was anticipated from the May 11 announcement; therefore, it lacks surprise factor (Routine).
- Issuing shares at $0.05 when trading near $0.03-$0.04 suggests creditors accepted a premium over market price to exit, but highlights an inability to pay cash obligations.
- The related party nature of the transaction raises governance concerns regarding insider control and potential conflicts of interest in debt resolution.
- Combined with the April 27 customer default (Material - Negative), this reinforces a narrative of severe liquidity distress and operational dependency on a single failing client.
- No material upside is introduced; the news merely resolves a liability at the cost of equity, which is negative for existing shareholders due to dilution.
XIGM · Price
Company Overview
- Xigem Technologies operates primarily through its EchoDigital business unit.
- The company relies heavily on a single customer, Carnance Inc., for revenue in this segment.
- Flagship projects involve digital health solutions or management services linked to the Tripartite Loan Agreement with Physiomed Health Inc.
- Development status is currently compromised by the default of the primary customer and reliance on equity issuance for operational funding.